The failure of Pfizer Inc.’s obesity pill, its highest profile experimental drug, raises the odds that the drugmaker will ...

Pfizer just pulled the plug on its daily weight-loss pill, danuglipron, after a clinical trial flagged a potential ...

Signs of potential liver damage in a study participant led the company to abandon danuglipron, a drug it hoped would help it ...

Pfizer Inc. has said it will discontinue development of its closely watched obesity pill, danuglipron, dealing a severe blow ...

When some of America’s most-influential CEOs were asked recently how much the stock market would need to fall before they ...

With the discontinuation of danuglipron, Pfizer is now down to one clinical-stage obesity asset: the oral GIP analog ...

(Reuters) -Institutional Shareholder Services has recommended Pfizer investors reject a proposal on executive compensation ...

China is prepared for “possible unexpected shocks,” Premier Li Qiang told a gathering of global executives in Beijing, where he urged them to “resist protectionism” and defend globalization.

Novartis plans to build seven new facilities in the U.S., touting the creation of up to 1,000 new jobs at the company. The ...

BEIJING (AP) — China’s Premier Li Qiang said Sunday that Beijing and Washington should choose dialogue instead of confrontation, as the two countries are locked in rising friction over trade tariffs ...